关注
Petri Pölönen, PhD
Petri Pölönen, PhD
在 stjude.org 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Role of the Keap1–Nrf2 pathway in cancer
HM Leinonen, E Kansanen, P Pölönen, M Heinäniemi, AL Levonen
Advances in cancer research 122, 281-320, 2014
1912014
Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity
O Dufva, J Koski, P Maliniemi, A Ianevski, J Klievink, J Leitner, P Pölönen, ...
Blood, The Journal of the American Society of Hematology 135 (9), 597-609, 2020
1862020
Immunogenomic landscape of hematological malignancies
O Dufva, P Pölönen, O Brück, MAI Keränen, J Klievink, J Mehtonen, ...
Cancer Cell 38 (3), 380-399. e13, 2020
1572020
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
H Kuusanmäki, AM Leppä, P Pölönen, M Kontro, O Dufva, D Deb, ...
Haematologica 105 (3), 708, 2020
1392020
Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia
LE Montefiori, S Bendig, Z Gu, X Chen, P Pölönen, X Ma, A Murison, ...
Cancer discovery 11 (11), 2846-2867, 2021
1102021
Dysregulation of the Keap1–Nrf2 pathway in cancer
HM Leinonen, E Kansanen, P Pölönen, M Heinäniemi, AL Levonen
Biochemical Society Transactions 43 (4), 645-649, 2015
832015
Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma
P Pölönen, A Jawahar Deen, HM Leinonen, HK Jyrkkänen, S Kuosmanen, ...
Oncogene 38 (50), 7473-7490, 2019
802019
Analysis of primary microRNA loci from nascent transcriptomes reveals regulatory domains governed by chromatin architecture
M Bouvy-Liivrand, A Hernández de Sande, P Pölönen, J Mehtonen, ...
Nucleic acids research 45 (17), 9837-9849, 2017
552017
Signalling input from divergent pathways subverts B cell transformation
LN Chan, MA Murakami, ME Robinson, R Caeser, T Sadras, J Lee, ...
Nature 583 (7818), 845-851, 2020
502020
The effects of sequence variation on genome-wide NRF2 binding—new target genes and regulatory SNPs
SM Kuosmanen, S Viitala, T Laitinen, M Peräkylä, P Pölönen, ...
Nucleic acids research 44 (4), 1760-1775, 2016
432016
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
H Kuusanmäki, O Dufva, M Vähä-Koskela, AM Leppä, J Huuhtanen, ...
Blood 141 (13), 1610-1625, 2023
422023
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
Leukemia 37 (518-528. doi: 10.1038/s41375-022-0), 2023
422023
In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL
S Laukkanen, T Grönroos, P Pölönen, H Kuusanmäki, J Mehtonen, ...
Blood cancer journal 7 (9), e604-e604, 2017
332017
Hemap: an interactive online resource for characterizing molecular phenotypes across hematologic malignancies
P Pölönen, J Mehtonen, J Lin, T Liuksiala, S Häyrynen, S Teppo, ...
Cancer research 79 (10), 2466-2479, 2019
292019
Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma
H Sallinen, S Janhonen, P Pölönen, H Niskanen, OH Liu, A Kivelä, ...
BMC cancer 19, 1-11, 2019
242019
Profiling of primary and mature miRNA expression in atherosclerosis-associated cell types
PR Moreau, V Tomas Bosch, M Bouvy-Liivrand, K Õunap, T Örd, ...
Arteriosclerosis, thrombosis, and vascular biology 41 (7), 2149-2167, 2021
202021
Data-driven characterization of molecular phenotypes across heterogeneous sample collections
J Mehtonen, P Pölönen, S Häyrynen, O Dufva, J Lin, T Liuksiala, ...
Nucleic acids research 47 (13), e76-e76, 2019
202019
A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies
J Härkönen, P Pölönen, AJ Deen, I Selvarajan, HR Teppo, EY Dimova, ...
Redox Biology 61, 102644, 2023
152023
Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers
O Dufva, S Gandolfi, J Huuhtanen, O Dashevsky, H Duàn, K Saeed, ...
Immunity 56 (12), 2816-2835. e13, 2023
132023
Comprehensive genome characterization of childhood T-ALL links oncogene activation mechanism and subtypes to prognosis
P Pölönen, A Elsayed, D Di Giacomo, L Montefiori, S Kimura, J Myers, ...
Blood 140 (Supplement 1), 1727-1729, 2022
82022
系统目前无法执行此操作,请稍后再试。
文章 1–20